Related Experiment Video
Updated: Jul 22, 2026

Study of Experimental Organ Donation Models for Lung Transplantation
Published on: March 15, 2024
Thoracic organ transplantation in the United States, 1995-2004
J B Orens1, T H Shearon, R S Freudenberger
1Johns Hopkins University School of Medicine, Baltimore, MD, USA. jorens@jhmi.edu
Insights
Thoracic organ transplantation trends show declining heart transplant waiting lists and improved survival rates. Lung transplant recipients also experienced decreased waiting times and better survival outcomes.
Area of Science:
- Cardiology
- Pulmonology
- Transplant Surgery
Background:
- Review of thoracic organ transplantation trends using data from the Organ Procurement and Transplantation Network (OPTN) and Scientific Registry of Transplant Recipients (SRTR) between 1995 and 2004.
- Analysis focuses on heart, lung, and combined heart-lung transplantation, examining waiting list dynamics, patient survival, and common indications.
Observation:
- The number of patients on the heart transplant waiting list decreased, with fewer patients listed for coronary artery disease.
- Waiting times and waiting list mortality for heart transplants declined significantly.
- Fewer heart transplants were performed in 2004 compared to 1995, but adjusted 1-year and 5-year patient survival rates improved.
Findings:
- Emphysema, idiopathic pulmonary fibrosis, and cystic fibrosis were primary indications for lung transplants in 2004.
- Waiting times for lung transplantation decreased between 1999 and 2004, alongside reduced waiting list mortality.
- One-year survival rates for lung transplantation showed significant improvement over the decade.
Implications:
- Improved survival rates suggest advancements in surgical techniques, post-operative care, and donor organ management for heart and lung transplantation.
- The low number of combined heart-lung transplants performed (39 in 2004) and their poorer survival rates indicate potential challenges or specific indications for this procedure.
- These trends highlight the evolving landscape of thoracic organ transplantation, emphasizing improved outcomes for single-organ transplants while underscoring areas for further investigation in combined procedures.
Abstract:
This article reviews trends in thoracic organ transplantation based on OPTN/SRTR data from 1995 to 2004. The number of active waiting list patients for heart transplants continues to decline, primarily because there are fewer patients with coronary artery disease listed for transplantation. Waiting times for heart transplantation have decreased, and waiting list deaths also have declined, from 259 per 1000 patient-years at risk in 1995 to 156 in 2004. Fewer heart transplants were performed in 2004 than in 1995, but adjusted patient survival increased to 88% at 1 year and 73% at 5 years. Emphysema, idiopathic pulmonary fibrosis and cystic fibrosis were the most common indications among lung transplant recipients in 2004. Waiting time for lung transplantation decreased between 1999 and 2004. Waiting list mortality decreased to 134 per 1000 patient-years at risk in 2004. One-year survival following transplantation has improved significantly in the past decade. The number of combined heart-lung transplants performed in the United States remains low, with only 39 performed in 2004. Overall unadjusted survival, at 58% at 1 year and 40% at 5 years, is lower among heart-lung recipients than among either heart or lung recipients alone.
Related Concept Videos
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Kidney Transplant I: Introduction

